ARCHIVES

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

NIH Breaks Ground For Clinical Center

November 14, 1997

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

Brooks Wins ACS Award. NCI Would Get $4.725 Billion, 12% Increase, In Bush Budget.

February 8, 2002

Roswell Park Celebrates 50th Anniversary of Pivotal Congressional Visit

October 20, 2021

NCI Advisory Group, Other Cancer Meetings

January 2, 1981